ESTABLISHMENT OF LONG-TERM IN-VITRO CULTURES OF HUMAN OVARIAN CYSTADENOMAS AND LMP TUMORS AND EXAMINATION OF THEIR SPECTRUM OF EXPRESSION OF MATRIX-DEGRADING PROTEINASES
Mp. Luo et al., ESTABLISHMENT OF LONG-TERM IN-VITRO CULTURES OF HUMAN OVARIAN CYSTADENOMAS AND LMP TUMORS AND EXAMINATION OF THEIR SPECTRUM OF EXPRESSION OF MATRIX-DEGRADING PROTEINASES, Gynecologic oncology, 67(3), 1997, pp. 277-284
Objectives. To obtain long-term cultures of ovarian cystadenomas and o
varian tumors of low malignant potential (LMP) displaying gene express
ion patterns similar to those found in vivo and test the hypothesis th
at such cultures would express different levels of matrix-degrading pr
oteinases than cultured ovarian carcinomas. Methods. Transfection with
an adenoviral expression vector for simian virus 40 (SV40) large T an
tigen was used to establish long-term cultures of the above tumors, Le
vels of expression of various genes were evaluated using molecular bio
logical and immunohistochemical approaches, Zymography and reverse zym
ography were used to examine the activity of various metalloproteinase
s and plasminogen activators (PA), Two-sided P values for differences
in plasminogen activator expression between different cell types were
evaluated by Fisher's exact test. Results. Long-term cultures derived
from cystadenomas and LMP tumors were obtained which formed colonies o
n semisolid supports, but were not tumorigenic in nude mice, The cultu
red cells expressed keratin, estrogen receptor, gonadotropin receptors
, BRCA1, and originated from monoclonal populations, There was no appa
rent association between the malignant phenotype and the expression of
either matrix metalloproteinases or tissue inhibitors of metalloprote
inases. However, a correlation was seen between this phenotype and exp
ression of urokinase (uPA) and tissue type (tPA) plasminogen activator
s (P = 0.08 and 0.02 respectively). Conclusions. The above cell strain
s provide a useful model for investigating various aspects of the biol
ogy of benign ovarian tumors, including their response to steroid and
gonadotropin hormones, and the role of specific proteinases in the acq
uisition of invasive and metastatic abilities. (C) 1997 Academic Press
.